(February 20, 2023) HBI and Josh Kesselman are no strangers to generating media attention. However, this time, the headlines aren't exactly positive.

The use of delta-9-THCO and delta-8-THCO has surged among cannabis consumers, driven by their high potency levels. However, the U.S. DEA has just designated these two compounds as Schedule I controlled substances, thereby making them federally illegal in the country.